AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-3.4%
5Y CAGR+39.2%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-3.4%/yr
Annual compound
5Y CAGR
+39.2%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
5.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$38.11M-30.1%
2024$54.55M-21.7%
2023$69.64M+64.8%
2022$42.26M+95.9%
2021$21.57M+196.2%
2020$7.28M-76.6%
2019$31.07M-